VANCOCIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Vancocin, and when can generic versions of Vancocin launch?
Vancocin is a drug marketed by Ani Pharms and Steriscience and is included in six NDAs.
The generic ingredient in VANCOCIN is vancomycin hydrochloride. There are twenty-two drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the vancomycin hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Vancocin
A generic version of VANCOCIN was approved as vancomycin hydrochloride by FRESENIUS KABI USA on March 17th, 1987.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for VANCOCIN?
- What are the global sales for VANCOCIN?
- What is Average Wholesale Price for VANCOCIN?
Summary for VANCOCIN
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 6 |
| Drug Prices: | Drug price information for VANCOCIN |
| What excipients (inactive ingredients) are in VANCOCIN? | VANCOCIN excipients list |
| DailyMed Link: | VANCOCIN at DailyMed |


